Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin in Myocardial Infarction
NCT00648089Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Apr 2008
- Primary completion
- Dec 2010
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of epoetin beta in myocardial infarction (MI) (2 arms), sponsored by Centre Hospitalier Universitaire d'Angers. Primary endpoint: Changes in infarct size as assessed by magnetic resonance imaging at 3 months. Started Apr 2008; status: completed.
02
Drugs
epoetin beta
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00648089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00648089.